Joleen Hubbard, MD

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    Merck
    Topic:
    Advisory Board
    Date added:
    08/05/2023
    Date updated:
    05/23/2024
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    Bayer
    Topic:
    Advisory Board
    Date added:
    08/05/2023
    Date updated:
    05/23/2024
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    BeiGene
    Topic:
    Advisory Board
    Date added:
    08/05/2023
    Date updated:
    05/23/2024
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    Incyte
    Topic:
    Advisory Board
    Date added:
    08/05/2023
    Date updated:
    05/23/2024
  • Attribution:
    Other
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Merck
    Topic:
    Research Support
    Date added:
    08/05/2023
    Date updated:
    05/23/2024
    Relationship end date:
    07/15/2023
  • Attribution:
    Other
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Treos Bio
    Topic:
    Research Support
    Date added:
    08/05/2023
    Date updated:
    05/23/2024
    Relationship end date:
    07/15/2023
  • Attribution:
    Other
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Bayer
    Topic:
    Research Support
    Date added:
    08/05/2023
    Date updated:
    05/23/2024
    Relationship end date:
    07/15/2023
  • Attribution:
    Other
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Incyte
    Topic:
    Research Support
    Date added:
    08/05/2023
    Date updated:
    05/23/2024
    Relationship end date:
    07/15/2023
  • Attribution:
    Other
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    TriOncology
    Topic:
    Research Support
    Date added:
    08/05/2023
    Date updated:
    05/23/2024
    Relationship end date:
    07/15/2023
  • Attribution:
    Other
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Seattle Genetics
    Topic:
    Research Support
    Date added:
    08/05/2023
    Date updated:
    05/23/2024
    Relationship end date:
    07/15/2023

Pages

Return to Best of ASCO 2024, Minneapolis